Browsing Pharmacy Research by Subject "Atrial Fibrillation"
Now showing items 1-1 of 1
-
Prescribers' perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation.
( Centro de Investigaciones y Publicaciones Farmaceuticas , 2020 , Article)There is an acknowledged lack of robust and rigorous research focusing on the perspectives of those prescribing direct acting oral anticoagulants (DOACs) for non-valvular atrial fibrillation (AF). The objective was to ...